Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-89
Closed -$401 7868
2025
Q4
$401 Sell
89
-93
-51% -$476 ﹤0.01% 7474
2025
Q3
$980 Sell
182
-807
-82% -$4.37K ﹤0.01% 7361
2025
Q2
$5.34K Buy
989
+109
+12% +$432 ﹤0.01% 6507
2025
Q1
$2.48K Sell
880
-200
-19% -$696 ﹤0.01% 6513
2024
Q4
$3.38K Sell
1,080
-675
-38% -$1.95K ﹤0.01% 6389
2024
Q3
$5.17K Buy
1,755
+1,070
+156% +$3.52K ﹤0.01% 6176
2024
Q2
$2.32K Buy
685
+164
+31% +$536 ﹤0.01% 6539
2024
Q1
$1.58K Sell
521
-338
-39% -$1.19K ﹤0.01% 6557
2023
Q4
$3.61K Sell
859
-1,331
-61% -$7.22K ﹤0.01% 6298
2023
Q3
$15K Buy
2,190
+1,014
+86% +$8.96K ﹤0.01% 5709
2023
Q2
$12.2K Buy
1,176
+23
+2% +$206 ﹤0.01% 5863
2023
Q1
$8.03K Sell
1,153
-60
-5% -$523 ﹤0.01% 6104
2022
Q4
$7K Sell
1,213
-135
-10% -$997 ﹤0.01% 6111
2022
Q3
$11K Sell
1,348
-100
-7% -$1.17K ﹤0.01% 5955
2022
Q2
$19K Sell
1,448
-179
-11% -$2.96K ﹤0.01% 5643
2022
Q1
$32K Buy
1,627
+57
+4% +$1.14K ﹤0.01% 5399
2021
Q4
$52K Sell
1,570
-330
-17% -$13.3K ﹤0.01% 5114
2021
Q3
$104K Buy
1,900
+860
+83% +$51.8K ﹤0.01% 4492
2021
Q2
$76K Sell
1,040
-57
-5% -$5.7K ﹤0.01% 4713
2021
Q1
$100K Buy
1,097
+551
+101% +$53.5K ﹤0.01% 4337
2020
Q4
$44K Sell
546
-430
-44% -$32.9K ﹤0.01% 4631
2020
Q3
$45K Buy
+976
New +$54.4K ﹤0.01% 4370

Osaic Holdings's CVAC Position: Q1 2026 in Review

Osaic Holdings sold out of CureVac (CVAC) in Q1 2026, closing a stake of 89 shares — an estimated $401 sold.

Osaic Holdings first reported a position in CVAC in Q3 2020 and held it in 22 quarters. The position peaked at $104K in Q3 2021. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.

  • Osaic Holdings reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
  • Osaic Holdings sold 89 CureVac shares in Q1 2026, an estimated $401.
  • Osaic Holdings first reported a position in CureVac in Q3 2020 and held it in 22 quarters.
  • Osaic Holdings's CureVac position peaked at $104K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.